Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: Role of local treatments

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Navarria, Pierina ^a   Ascolese, Anna M ^a   Tomatis, Stefano ^a   Cozzi, Luca ^b   De Rose, Fiorenza ^a   Mancosu, Pietro ^a   Alongi, Filippo ^a   Clerici, Elena ^a   Lobefalo, Francesca ^a   Tozzi, Angelo ^a   Reggiori, Giacomo ^a   Fogliata, Antonella ^b   Scorsetti, Marta ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; COLORECTAL CANCER; CONE BEAM COMPUTED TOMOGRAPHY; DISEASE COURSE; DISEASE SPECIFIC SURVIVAL; DOSIMETRY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCAL THERAPY; LUNG FIBROSIS; LUNG LESION; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; ORGANS AT RISK; OVERALL SURVIVAL; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; SARCOMA; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME; UROGENITAL TRACT CANCER; VERY ELDERLY; LUNG NEOPLASMS; METASTASIS; MIDDLE AGED; MORTALITY; NEOPLASMS; PROCEDURES; RADIOMETRY; RADIOSURGERY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; PROSPECTIVE STUDIES; RADIOMETRY; RADIOSURGERY; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 84899618170     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-91     Document Type: Article

References (37)

1. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol 1995, 13:8-10.
2. Lo SS, Fakiris AJ, Teh BS, Cardenes HR, Henderson MA, Forquer JA, Papiez L, McGarry RC, Wang JZ, Li K, Kayr NA, Timmerman RD. Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther 2009, 9:621-635. 10.1586/era.09.15, 19445579.
3. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997, 113:37-49. 10.1016/S0022-5223(97)70397-0, 9011700.
4. Fong Y, Cohen AM, Fortner JG, Enker WE, Trunbull AD, Coit DG, Marrero AM, Prasad M, Blumgart LH, Brennan MF. Liver resection for colorectal metastases. J Clin Oncol 1997, 15:938-946.
5. Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, NBagorney DM, McWilliams RR. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol 2009, 27:3677-3683. 10.1200/JCO.2008.20.5278, 2720081, 19470929.
6. Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 2010, 7:44-54. 10.1038/nrclinonc.2009.188, 19997074.
7. Lo SS, Moffatt-Bruce SD, Dawson LA, Schwarz RE, Teh BS, Mayr NA, Lu JJ, Grecula JC, Olencki TE, Timmerman RD. The role of local therapy in the management of lung and liver oligometastases. Nat Rev Clin Oncol 2011, 8:405-416. 10.1038/nrclinonc.2011.75, 21606970.
8. Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, Mizowaki T, Yano S, Hiraoka M. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008, 2:398-403.
9. Schefter TE, Rusthoven KE, Kavanagh BD, Burri S, Chen C, Cardenes H, Chidel M, Pugh T, Kane M, Gaspar L, Schefter T. Multiinstitutional phase I/II trial of stereotactic body radiation therapy for lung metastases. J Clin Oncol 2009, 27:1579-1584. 10.1200/JCO.2008.19.6386, 19255320.
10. Casamassima F, Livi L, Masciullo S, Menichelli C, Masi L, Meattini I, Bonucci I, Agresti B, Simontacchi G, Doro R. Stereotactic radiotherapy for adrenal gland metastases: università of FLorence experience. Int J Radiat Oncol Boil Phys 2012, 82:919-923.
11. Bonomo P, Livi L, Rampini A, Meattini I, Agresti B, Simontacchi G, Paiar F, Mangoni M, Bonucci I, Greto D, Masi L, Doro R, Marrazzo L, Biti G, Agresti B, Simontacchi G, Paiar F, Mangoni M, Bonucci I, Greto D, Masi L, Doro R, Marrazzo L, Biti G. Stereotactic body radiotherapy for cardiac and paracardiac metastases: University of Florence experience. Radiol Med 2013, 118:1055-1065. 10.1007/s11547-013-0932-0, 23716288.
12. Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013, 105:256-265. 10.1093/jnci/djs629, 3576324, 23291374.
13. Okunieff P, Petersen AL, Philip A, Milano M, Katz A, Boros L, Schell M. Stereotactic body radiation therapy (SBRT) for lung metastases. Acta Oncol 2006, 808-817.
14. Le QT, Loo BW, Ho A, Cotrutz C, Koong A, Wakelee H, Kee S, Constantinescuo D, Whyte R, Donington J. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol 2006, 1:802-809. 10.1097/01243894-200610000-00008, 17409963.
15. Norihisa Y, Nagata Y, Takayama K, Matsuo Y, Sakamoto T, Sakamoto M, Misowaki T, Yano S, Hiraoka M. Stereotactic body radiotherapy for oligometastatic lung tumors. Int J Radiat Oncol Biol Phys 2008, 398-403.
16. Salama JK, Hasselle MD, Chmura SJ, Malik R, Mehta N, Yenice K, Villaflor V, Stadler W, Hoffman P, Cohen E, Connell P, Haraf D, Vokes E, Hellman S, Weichselbam R. Stereotactic Body Radiotherapy for Multisite Extracranial Oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease. Cancer 2011, 118:2962-2970.
17. Rusthoven KE, Kavanagh BD, Cardenes H, Stieber V, Burri S, Feigenberg S, Chidel M, Pugh T, Franklin W, Kane M, Gaspar L, Schefter T. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27:1572-1578. 10.1200/JCO.2008.19.6329, 19255321.
18. Ricardi U, Filippi AR, Guarnieri A, Ragona R, Mantovani C, Giglioli F, Botticella A, Ciammella P, Iftode C, Buffoni L, Ruffini E, Scagliotti G. Stereotactic body radiation therapy for lung metastases. Lung Cancer 2012, 75:77-81. 10.1016/j.lungcan.2011.04.021, 21726918.
19. Milano MT, Katz AW, Muhs AG, Philip A, Bucholz D, Schell M, Okunieff P. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer 2008, 112:650-658. 10.1002/cncr.23209, 18072260.
20. Milano MT, Katz AW, Schell MC, Philip A, Okunieff P. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:1516-1522. 10.1016/j.ijrobp.2008.03.044, 18495378.
21. Kang JK, Kim MS, Kim JH, Yoo S, Cho C, Yang K, Yoo H, Seo Y, Lee D, Kang H, Kim Y, Shin U. Oligometastases confined one organ from colorectal cancer treated by SBRT. Clin Exp Metastasis 2010, 27:273-278. 10.1007/s10585-010-9325-0, 20373133.
22. Inoue T, Katoh N, Aoyama H, Onimaru R, Taguchi H, Onodera S, Yamaguchi S, Shirato H. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. Jpn J Clin Oncol 2010, 40:788-794. 10.1093/jjco/hyq044, 20406944.
23. Alongi F, Arcangeli S, Filippi AR, Ricardi U, Scorsetti M. Review and use of stereotactic body radiation Therapy for oligometastases. Oncologist 2012, 17:1100-1107. 10.1634/theoncologist.2012-0092, 3425528, 22723509.
24. Stinauer MA, Kavanagh BD, Schefter TE, Gonzalez R, Flaig T, Lewis K, Robinson W, Chidel M, Glode M, Raben D. Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control. Radiat Oncol 2011, 6:34. 10.1186/1748-717X-6-34, 3094365, 21477295.
25. Milano MT, Katz AW, Zhang H, Okunieff P. Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. Int J Radiat Oncol Biol Phys 2012, 83:878-886. 10.1016/j.ijrobp.2011.08.036, 22172903.
26. Zhang Y, Xiao JP, Zhang HZ, Yin W, Hu Y, Song Y, Zhang L, Liao Z, Li Y. Stereotactic body radiation therapy favors long-term overall survival in patients with lung metastases: five-year experience of a single-institution. Chin Med J (Engl) 2011, 124:4132-4137.
27. Inoue T, Katoh N, Aoyama H, Onimaru R, Taguchi H, Onodera S, Yamaguchi S, Shirato H. Clinical outcomes of stereotactic brain and/or body radiotherapy for patients with oligometastatic lesions. Jpn J Clin Oncol 2010, 40:788-794. 10.1093/jjco/hyq044, 20406944.
28. Milano MT, Katz AW, Okunieff P. Patterns of recurrence after curative-intent radiation for oligometastases confi ned to one organ. Am J Clin Oncol 2010, 33:157-163.
29. Holy R, Piroth M, Pinkawa M, Eble MJ. Stereotactic body radiation therapy (SBRT) for treatment of adrenal gland metastases from non-small cell lung cancer. Strahlenther Onkol 2011, 187:245-251. 10.1007/s00066-011-2192-z, 21424513.
30. Scorsetti M, Mancosu P, Navarria P, Tozzi A, Castiglioni S, Clerici E, Reggiori G, Lobefalo F, Fogliata A, Cozzi L. Stereotactic body radiation therapy (SBRT) for adrenal metastases: a feasibility study of advanced techniques with modulated photons and protons. Strahlenther Onkol 2011, 187:238-244. 10.1007/s00066-011-2207-9, 21437767.
31. Bignardi M, Navarria P, Mancosu P, Cozzi L, Fogliata A, Tozzi A, Castiglioni S, Carnaghi C, Tronconi M, Santoro A, Scorsetti M. Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases. Int J Radiat Oncol Biol Phys 2011, 81:831-838. 10.1016/j.ijrobp.2010.05.032, 20800375.
32. Wersäll PJ, Blomgren H, Lax I, Kalkner K, Linder C, Lundell G, Nilsson B, Nilsson S, Naslund I, Pisa P, Svedman C. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005, 77:88-95. 10.1016/j.radonc.2005.03.022, 15972239.
33. Choi CW, Cho CK, Yoo SY, Seo Y, Kang J, Lee D, Lee K, Lee E, Rhu S, Choi S, Kim M, Kim B. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer. Int J Radiat Oncol Biol Phys 2009, 74:147-153. 10.1016/j.ijrobp.2008.07.020, 18990511.
34. Zelefsky MJ, Greco C, Motzer R, Madsanoc J, Pei X, Lovelock M, Mechalakos J, Zatcky J, Fuks Z, Yamada Y. Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinoma. Int J Radiat Oncol Biol Phys 2011, 82:1744-1778.
35. Wang JZ, Huang Z, Lo SS, Wang J, Jia G, Yuh W, Johnke R. A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy. Sci Transl Med 2010, 2:39-48.
36. Park C, Papiez L, Zhang S, Story M, Timmerman R. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys 2008, 70:847-852. 10.1016/j.ijrobp.2007.10.059, 18262098.
37. Hasselle MD, Haraf DJ, Rusthoven KE, Golden D, Salgia R, Villaflor V, Shah N, Hoffman P, Chmura S, Connell P, Vokes E, Weichselbaum R, Salama J. Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer. J Thorac Oncol 2012, 7:376-381. 10.1097/JTO.0b013e31824166a5, 22198429.